Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'fda risk'
fda risk published presentations and documents on DocSlides.
FDA Basics 21 CRF 50 –Protection of Human Subjects
by caroline
21 CFR 56 - IRBs. 21 CFR 312 - Drugs. 21 CFR 812 â...
FDA’s Center for Devices and Radiological Health: Partner
by aaron
Jeff Shuren, MD, JD. Center for Devices and Radio...
Tina Morrison U.S. FDA March 23, 2017
by celsa-spraggs
FDA Modeling and Simulation Working Group. Sponso...
FDA Overview of the Process for Clearance and Approval of Mass Spectrometry-based In vitro Diagnost
by tatiana-dople
MSACL. April 4, 2019. Majda Haznadar, Kris Roth, ...
FDA’s Center for Devices and Radiological Health: Current Status and Future Direction
by carny
Jeff Shuren, MD, JD. Center for Devices and Radiol...
An Update on FDA Regulations: E-Cigarettes &
by lucinda
Vaping. Deborah J. Ossip, PhD. Professor and Direc...
FDA Regulatory Requirements for Successful Biomarker Applications
by oliver
Early Detection Research Network. September 9, 201...
ROMA – Overview and FDA Lessons
by tristan742
Clinical Situation: . A woman with a pelvic mass. ...
FDA Tree Nut Risk Assessment
by alexa-scheidler
and Human Salmonellosis. National Pecan . Sheller...
Advancing the science of risk-based criteria for agricultural water quality:
by shoffer
. Industry perspectives on the use of risk-based a...
DRAFT FDASIA Committee Report
by briana-ranney
David W. Bates MD, . MSc. , Chair. 1. Committee M...
Medical Device Cybersecurity: FDA Perspective
by delcy
Suzanne B. Schwartz, MD, MBA. Associate Director f...
FDA Regulatory Framework for
by giovanna-bartolotta
Devices Applied to HIT. Bradley Merrill Thompson....
FDA Regulatory Framework for
by marina-yarberry
Devices Applied to HIT. Bradley Merrill Thompson....
It is the policy of the University of Arkansas for Med
by ellena-manuel
All individuals who are in a position to con...
FDA Transmissible Spongiform Encephalopathies
by kittie-lecroy
Advisory Committee. 23. rd. Meeting 01 August 20...
Regulatory Framework for
by tawny-fly
Food Safety at FDA. July 12, 2018. What is Food?....
medical device cybersecurity
by pamela
Seth D Carmody . phD. ACT-IAC cyber COI membership...
Welcome Once you’ve logged into
by dora
Webex. , please select one of the following audio ...
TABLE OF CONTENTS
by tracy
I. INTRODUCTION .....................................
Human Factors in Digital Health
by Daredevil
Kimberly Kontson. , Biomedical Engineer, CDRH, FDA...
IND Determinations An IRB
by molly
Infoshort. August 2013. IND. An Investigational Ne...
Assessing and Monitoring for Intravascular Injections
by nicole
Henry Lee, MD. Office of Health Technology 4: Surg...
Lab Oversight and Enforcement
by min-jolicoeur
Joyce E. Gresko. Alston & Bird LLP. (202) 239...
Needed Regulatory Changes
by liane-varnes
A report of the typist for the Regulation Subgrou...
Regulatory weaknesses A report of the typist for the Regulation Subgroup
by phoebe-click
(i.e. no one has seen or approved this). Draft 07...
Current FDA Enforcement Trends –
by stefany-barnette
Avoiding A Criminal Investigation. . July 12, 2...
IND Determinations
by lindy-dunigan
An IRB . Infoshort. August 2013. IND. An Investig...
IND Determinations
by debby-jeon
An IRB . Infoshort. August 2013. IND. An Investig...
Handling Regulatory Inspections
by trish-goza
Denise Webster. Fresh & Easy. April 3, 2014. ...
UC DAVIS OFFICE OF RESEARCH
by kittie-lecroy
UCD Human Research Protection Program. . Accredi...
Adaptive Designs to Demonstrate Risk Reduction
by natalia-silvester
in Cardiovascular Outcome Trials. A Case Study o...
educate • fund • connect • support
by briana-ranney
MIAP – Introduction to INDs and IDEs. E Mitchel...
The Impact of FSMA Rules on
by alida-meadow
Sustainable Agriculture and . Local Food Systems....
Nor Cal SOT Evaluation of Carcinogenic Risk for Biotechnology-Derived Therapeutics
by danika-pritchard
Nor Cal SOT Evaluation of Carcinogenic Risk for B...
Introduction to flood risk assessment with HEC-FDA
by smith
Richard J. Nugent III, Ph.D. . Economist, HEC-FDA ...
Risk Determinations and Research with Children
by yoshiko-marsland
Angela Bain, IRB Specialist. abain@uga.edu. . 70...
Team NASA Assaf Anyamba Jennifer Small
by anderson
Richard Damoah. (GSFC). FDA. David . Oryang. . We...
Working with Investigational Assay Results
by phoebe
Week 6- Correlative Trials- A Case Based Approach....
Aflatoxin Risk Management
by genevieve
Tim . Herrman. Professor, State Chemist and Direct...
Load More...